Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation
Tóm tắt
Từ khóa
Tài liệu tham khảo
Schmitz, 1999, Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis,, Gastroenterology, 116, 301, 10.1016/S0016-5085(99)70126-5
Clayburgh, 2004, A porous defense: the leaky epithelial barrier in intestinal disease, Lab Invest, 84, 282, 10.1038/labinvest.3700050
Prasad, 2005, Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells, Lab Invest, 85, 1139, 10.1038/labinvest.3700316
Zeissig, 2007, Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease, Gut, 56, 61, 10.1136/gut.2006.094375
Weber, 2007, Inflammatory bowel disease: is it really just another break in the wall?, Gut, 56, 6, 10.1136/gut.2006.104182
Clayburgh, 2005, Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo, J Clin Invest, 115, 2702, 10.1172/JCI24970
Graham, 2006, Tumor necrosis factor-induced long myosin light chain kinase transcription is regulated by differentiation-dependent signaling events. Characterization of the human long myosin light chain kinase promoter, J Biol Chem, 281, 26205, 10.1074/jbc.M602164200
Heller, 2005, Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution, Gastroenterology, 129, 550, 10.1016/j.gastro.2005.05.002
MacDonald, 1990, Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine, Clin Exp Immunol, 81, 301, 10.1111/j.1365-2249.1990.tb03334.x
Mankertz, 2000, Expression from the human occludin promoter is affected by tumor necrosis factor alpha and interferon gamma, J Cell Sci, 113, 2085, 10.1242/jcs.113.11.2085
Wang, 2005, Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression, Am J Pathol, 166, 409, 10.1016/S0002-9440(10)62264-X
Wang, 2006, IFN-gamma-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunction, Gastroenterology, 131, 1153, 10.1053/j.gastro.2006.08.022
Dhawan, 2005, Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer, J Clin Invest, 115, 1765, 10.1172/JCI24543
Matter, 2003, Signalling to and from tight junctions, Nat Rev Mol Cell Biol, 4, 225, 10.1038/nrm1055
Hewitt, 2006, The claudin gene family: expression in normal and neoplastic tissues, BMC Cancer, 6, 186, 10.1186/1471-2407-6-186
Kominsky, 2006, Claudins: emerging targets for cancer therapy, Expert Rev Mol Med, 8, 1, 10.1017/S1462399406000056
Soini, 2005, Expression of claudins 1, 2, 3, 4, 5 and 7 in various types of tumours, Histopathology, 46, 551, 10.1111/j.1365-2559.2005.02127.x
Swisshelm, 2005, Role of claudins in tumorigenesis, Adv Drug Deliv Rev, 57, 919, 10.1016/j.addr.2005.01.006
Morin, 2005, Claudin proteins in human cancer: promising new targets for diagnosis and therapy, Cancer Res, 65, 9603, 10.1158/0008-5472.CAN-05-2782
Michl, 2003, Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer, Cancer Res, 63, 6265
Gyorffy, 2005, Claudin expression in Barrett's esophagus and adenocarcinoma, Virchows Arch, 447, 961, 10.1007/s00428-005-0045-9
Lee, 2005, Loss of the tight junction protein claudin 4 correlates with histological growth-pattern and differentiation in advanced gastric adenocarcinoma, Oncol Rep, 13, 193
Grone, 2007, Differential expression of genes encoding tight junction proteins in colorectal cancer: frequent dysregulation of claudin-1, -8 and -12, Int J Colorectal Dis, 22, 651, 10.1007/s00384-006-0197-3
Kinugasa, 2007, Selective up-regulation of claudin-1 and claudin-2 in colorectal cancer, Anticancer Res, 27, 3729
Resnick, 2005, Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study, Mod Pathol, 18, 511, 10.1038/modpathol.3800301
Aung, 2006, Differential expression of claudin-2 in normal human tissues and gastrointestinal carcinomas, Virchows Arch, 448, 428, 10.1007/s00428-005-0120-2
Hahn-Stromberg, 2008, Disturbed expression of E-cadherin, beta-catenin and tight junction proteins in colon carcinoma is unrelated to growth pattern and genetic polymorphisms, APMIS, 116, 253, 10.1111/j.1600-0463.2008.00894.x
Miwa, 2001, Involvement of claudin-1 in the beta-catenin/Tcf signaling pathway and its frequent upregulation in human colorectal cancers, Oncol Res, 12, 469, 10.3727/096504001108747477
Mankertz, 2004, Functional crosstalk between Wnt signaling and Cdx-related transcriptional activation in the regulation of the claudin-2 promoter activity, Biochem Biophys Res Commun, 314, 1001, 10.1016/j.bbrc.2003.12.185
Eaden, 2004, Review article: colorectal carcinoma and inflammatory bowel disease, Aliment Pharmacol Ther, 20, 24, 10.1111/j.1365-2036.2004.02046.x
von Roon, 2007, The risk of cancer in patients with Crohn's disease, Dis Colon Rectum, 50, 839, 10.1007/s10350-006-0848-z
Bernstein, 2001, Cancer risk in patients with inflammatory bowel disease: a population-based study, Cancer, 91, 854, 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z
Itzkowitz, 2004, Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation, Am J Physiol Gastrointest Liver Physiol, 287, G7, 10.1152/ajpgi.00079.2004
Rutter, 2004, Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis, Gastroenterology, 126, 451, 10.1053/j.gastro.2003.11.010
Kumar, 1982, The histopathologic spectrum of acute self-limited colitis (acute infectious-type colitis), Am J Surg Pathol, 6, 523, 10.1097/00000478-198209000-00004
Surawicz, 1988, The role of rectal biopsy in infectious colitis, Am J Surg Pathol, 12, 82
Surawicz, 1984, Rectal biopsy helps to distinguish acute self-limited colitis from idiopathic inflammatory bowel disease, Gastroenterol, 86, 104, 10.1016/0016-5085(84)90595-X
Surawicz, 1994, Mucosal biopsy diagnosis of colitis: acute self-limited colitis and idiopathic inflammatory bowel disease, Gastroenterol, 107, 755, 10.1016/0016-5085(94)90124-4
Turner, 2006, Molecular basis of epithelial barrier regulation: from basic mechanisms to clinical application, Am J Pathol, 169, 1901, 10.2353/ajpath.2006.060681
Blair, 2006, Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel disease, Lab Invest, 86, 191, 10.1038/labinvest.3700373
Vagefi, 2005, Colorectal cancer in patients with inflammatory bowel disease, Clin Colorectal Cancer, 4, 313, 10.3816/CCC.2005.n.003
Fuss, 2004, Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis, J Clin Invest, 113, 1490, 10.1172/JCI19836